Fluid behind the eye builds up when the delicate barriers that normally keep blood vessels sealed begin to leak. This can happen in several different conditions, but the core problem is the same: fluid escapes from blood vessels in the back of the eye and collects in or beneath the retina, the light-sensitive tissue that sends visual signals to your brain. The most common causes include a stress-related condition called central serous chorioretinopathy, the wet form of macular degeneration, diabetic eye disease, blocked retinal veins, and inflammation inside the eye.
Central Serous Chorioretinopathy
Central serous chorioretinopathy (often shortened to CSC or CSCR) is one of the most common reasons fluid collects behind the retina, and it typically strikes adults between 20 and 50. The problem starts in the choroid, a dense layer of blood vessels that sits behind the retina and supplies it with oxygen. In CSC, those choroidal blood vessels become abnormally leaky. The excess fluid pushes through a protective cell layer called the retinal pigment epithelium, which normally acts like a seal between the blood supply and the retina. When pressure from the leaking vessels overwhelms that seal, fluid pools in the space between the retina and the pigment layer, creating a small pocket of detachment.
What makes the choroid leak in the first place isn’t entirely clear, but reduced blood flow and localized ischemia in parts of the choroid appear to play a role. Areas where blood drains slowly develop dilated veins and increased pressure, which forces plasma through vessel walls that would normally stay tight.
Several risk factors are well established. Psychological stress and “type A” personality traits are strongly associated with CSC. Corticosteroid medications, whether taken as pills, inhaled for asthma, or applied as skin creams, can trigger the condition. Steroids appear to alter the way the pigment epithelium pumps fluid and change the permeability of the blood-retinal barrier. Cases have been reported after as little as two weeks of oral steroid therapy.
The good news is that acute CSC resolves on its own in 80% to 90% of cases within two to three months, with fluid gradually reabsorbing and vision returning to normal or near-normal. When fluid persists beyond three months, the condition is classified as chronic and carries a worse outlook for vision recovery.
Wet Age-Related Macular Degeneration
Wet macular degeneration is a leading cause of severe vision loss in adults over 60, and fluid accumulation is its hallmark. Unlike CSC, where existing blood vessels leak, wet AMD involves the growth of entirely new, abnormal blood vessels underneath the retina. These vessels are fragile and poorly formed. They bleed and leak fluid into and beneath the retina, warping its structure and destroying the central vision you rely on for reading and recognizing faces.
The trigger for this abnormal vessel growth is a signaling protein called VEGF (vascular endothelial growth factor). In a healthy eye, VEGF helps maintain normal blood vessel function. In wet AMD, the retina produces too much of it, sending a constant signal that stimulates new vessel formation in the wrong place. Treatment focuses on blocking this protein with injections into the eye, which can slow or stop the leaking and, in many cases, improve vision.
Diabetic Macular Edema
Chronically high blood sugar damages the tiny capillaries that supply the retina. Over time, these vessels lose their ability to regulate blood flow and become increasingly permeable. The result is diabetic macular edema, where fluid leaks out of damaged capillaries and accumulates within the retina itself or in the space beneath it.
The process unfolds in stages. High blood sugar starves retinal tissue of oxygen, creating a state of hypoxia. The oxygen-deprived retina responds by ramping up VEGF production, the same growth factor involved in wet AMD, which further weakens vessel walls. At the same time, metabolic byproducts like sorbitol and lactate accumulate inside retinal cells, causing them to swell. This combination of leaking vessels and swollen cells disrupts the retina’s precisely layered structure.
The breakdown is really a balance problem: more fluid enters the retina than can drain out. As diabetes progresses, the retina’s ability to clear excess fluid deteriorates further, compounding the swelling. Diabetic macular edema can develop at any stage of diabetic retinopathy and is a major reason people with diabetes lose central vision.
Retinal Vein Occlusion
A retinal vein occlusion is essentially a blood clot in one of the veins that drains blood from the retina. When a vein is blocked, blood backs up behind the obstruction. The rising pressure inside the vein forces plasma and blood cells through the vessel walls and into surrounding retinal tissue, causing widespread swelling and hemorrhages. If the blockage affects the central retinal vein, the entire retina can be involved. If it affects a branch vein, the damage is confined to the area that vein drains.
Risk factors overlap heavily with cardiovascular disease: high blood pressure, high cholesterol, diabetes, and glaucoma all increase the likelihood of a retinal vein occlusion. The resulting macular edema is often treated with the same anti-VEGF injections used for wet AMD and diabetic eye disease.
Inflammation Inside the Eye
Uveitis, or inflammation of the eye’s middle layer, can also cause fluid to pool in the retina. In posterior uveitis (inflammation at the back of the eye), immune cells release a cascade of inflammatory chemicals. These include tumor necrosis factor alpha, interleukins, prostaglandins, and VEGF. Together, they break down the blood-retinal barrier, the same protective seal involved in other causes, and allow fluid to leak into the macula.
Uveitis can result from autoimmune diseases like sarcoidosis or Behçet’s disease, infections, or unknown causes. The fluid accumulation in uveitic macular edema tends to persist as long as the underlying inflammation is active, making control of the immune response essential for clearing the fluid.
What Fluid Behind the Eye Feels Like
The symptoms depend on where the fluid collects and how much accumulates, but certain visual changes are characteristic. Metamorphopsia, where straight lines appear wavy or bent, is one of the most common early signs. You might also notice micropsia, a strange perception that objects look smaller than they actually are. Blurred central vision, a dark or gray spot in the center of your visual field (a scotoma), and reduced ability to distinguish colors or contrast are all typical.
In central serous chorioretinopathy, people often describe a round or oval dim spot in the center of their vision. In retinal vein occlusion, the blurring or gray-out may be more diffuse. Some cases of mild macular edema produce no symptoms at all and are only caught during a routine eye exam.
How Fluid Behind the Eye Is Detected
The primary tool for detecting and monitoring fluid behind the eye is optical coherence tomography (OCT), a painless scan that takes cross-sectional images of the retina in extraordinary detail. OCT can distinguish between fluid sitting beneath the retina (subretinal fluid) and fluid trapped within the retina’s layers (intraretinal fluid). This distinction matters because different conditions produce different fluid patterns, and the location of the fluid influences treatment decisions.
Your eye doctor may also use fluorescein angiography, where a dye injected into a vein in your arm travels to the eye and highlights leaking blood vessels when photographed with a special camera. In conditions like CSC, a related imaging technique using a different dye (indocyanine green) can reveal abnormal blood flow patterns in the choroid that standard angiography misses.
Because the causes range from self-limiting conditions like acute CSC to sight-threatening diseases like wet AMD, identifying the specific source of leakage is critical for determining whether you need treatment, and if so, what kind. Most causes share a final common pathway of barrier breakdown and fluid leakage, but the upstream triggers, and therefore the treatments, are very different.